Eubiotics Market Report Scope & Overview:

The Eubiotics Market was valued at USD 7.51 Billion in 2025 and is expected to reach USD 16.27 Billion by 2035, growing at a CAGR of 8.17% from 2026 to 2035.

Eubiotics is one of those industry terms that sounds more technical than it needs to be, it is really just the umbrella category for feed additives, probiotics, prebiotics, organic acids, essential oils, that work with an animal's natural gut microbiome rather than against it, the way broad-spectrum antibiotics historically did. That distinction has become the whole point of the category's growth story: the EU's Regulation 2019/6 on veterinary medicinal products and the U.S. FDA's Guidance for Industry #213 have both compressed the timeline for antibiotic-free livestock transitions, and eubiotics have emerged as the most performance-validated alternative available at commercial scale. Poultry producers, facing the most direct regulatory exposure to antibiotic growth promoter phase-outs, have been the category's earliest and heaviest adopters.

In February 2025, Novonesis A/S acquired dsm-firmenich's stake in the Feed Enzyme Alliance for EUR 1.5 billion, dissolving the joint venture and taking over its sales and distribution activities to strengthen its animal biosolutions portfolio.

To Get More Information On Eubiotics Market - Request Free Sample Report

Eubiotics Market Trends

• Essential oils are gaining share fastest among eubiotic types as producers seek natural alternatives with strong antimicrobial properties.

• Aquaculture applications are expanding rapidly as shrimp and salmon farming intensifies across Southeast Asia and Scandinavia.

• Encapsulation technologies are improving probiotic survivability through feed processing and animal digestive tracts.

• Synbiotic formulations combining probiotics and prebiotics are gaining traction for their complementary gut health benefits.

• Precision livestock farming is creating demand for eubiotic formulations tailored to specific production stages and species.

U.S. Eubiotics Market Outlook

The U.S. Eubiotics Market was valued at USD 1.26 Billion in 2025 and is projected to reach USD 2.68 Billion by 2035, growing at a CAGR of 7.7% during 2026-2035.

FDA Guidance for Industry #213, which phased out the use of medically important antimicrobials for growth promotion purposes in livestock, did more than almost any single regulatory action to establish eubiotics as standard practice across U.S. poultry and swine production. Poultry producers in particular completed much of their transition years ago, which means growth in the U.S. market now comes more from formulation upgrades, synbiotics and encapsulated probiotics replacing older single-strain products, than from first-time adoption. Aquaculture represents a smaller but genuinely fast-growing application domestically, tracking the broader expansion of U.S. fish and shrimp farming operations. Swine producers have also increasingly adopted eubiotic programs as part of broader herd health strategies following African swine fever concerns that heightened biosecurity awareness industry-wide.

In January 2025, Evonik Industries AG launched Ecobiol Soluble Plus, a water-soluble probiotic for poultry built around Bacillus amyloliquefaciens CECT 5940, at the Poultry India event in Hyderabad.

Eubiotics Market Segment Analysis

• By Type, Probiotics segment dominated the Eubiotics Market in 2025 with 42% share; Essential Oils segment is the fastest-growing segment, registering a CAGR of 9.85% from 2026 to 2035.

• By Livestock, Poultry segment dominated the market in 2025 with 36.50% share; Aquaculture segment is the fastest-growing segment, registering a CAGR of 9.10% from 2026 to 2035.

• By Function, Gut Health segment dominated the market in 2025 with 44% share; Immune Support segment is the fastest-growing segment, registering a CAGR of 9.60% from 2026 to 2035.

• By Form, Dry segment dominated the market in 2025 with 68% share; Liquid segment is the fastest-growing segment, registering a CAGR of 8.80% from 2026 to 2035.

By Type, Probiotics Lead the Eubiotics Market While Essential Oils Gain Ground Fastest

Probiotics hold 42% of the Eubiotics Market, the largest single type category, benefiting from the deepest body of clinical and field research among all eubiotic types when it comes to demonstrating measurable improvements in feed conversion and animal performance. Live beneficial bacteria strains like Bacillus and Lactobacillus species have become close to industry-standard inclusions in poultry and swine diets, giving probiotics a research and adoption head start that newer eubiotic categories are still working to close.

Essential Oils are growing at a 9.85% CAGR, the fastest pace among types, as producers increasingly value their natural antimicrobial and anti-inflammatory properties as a genuinely plant-derived alternative to synthetic feed additives. Thymol, carvacrol, and other plant-derived compounds have accumulated growing research support for their gut health benefits, and their positioning as a fully natural ingredient category resonates particularly well with consumer-facing antibiotic-free and clean-label marketing claims.

By Livestock, Poultry Dominates While Aquaculture Emerges as the Fastest-Growing Segment

Poultry accounts for 36.50% of the Eubiotics Market by livestock type, the largest single category, reflecting the sector's front-line exposure to antibiotic growth promoter phase-outs and its short production cycles that make early-life gut health interventions especially consequential. Poultry alone represents nearly 40% of total global meat production, and that sheer production scale, combined with the industry's early and comprehensive shift away from antibiotics, has made it the eubiotics category's anchor application.

Aquaculture is growing fastest by livestock type, at a 9.10% CAGR, propelled by shrimp and salmon farming intensification across Southeast Asia and Scandinavia as global seafood demand continues outpacing what wild-catch fisheries can supply. Water-quality-sensitive aquaculture environments make gut health and immune function especially consequential, since disease outbreaks can spread through fish and shrimp populations faster than in most terrestrial livestock operations.

By Function, Gut Health Dominates While Immune Support Registers the Fastest Growth

Gut Health applications account for 44% of the market by function, the largest single category, reflecting how central digestive performance has become to virtually every modern livestock nutrition strategy across species. Improved gut integrity translates directly into better feed conversion ratios and reduced susceptibility to enteric disease, two outcomes that matter enormously to producer economics regardless of which specific livestock sector is involved.

Immune Support is the fastest-growing function, expanding at a 9.60% CAGR, as producers increasingly recognize that a healthy gut microbiome does more than aid digestion, it plays a direct role in an animal's overall immune resilience and disease resistance. This connection has become particularly relevant as antibiotic restrictions remove a tool producers previously relied on to manage disease outbreaks after the fact, pushing more investment toward preventive immune support instead.

By Form, Dry Dominates While Liquid Registers the Fastest Growth

Dry formulations account for 68% of the market in terms of formulation type, maintaining their dominance for the same reason as dry ingredients, which is that they have higher shelf life, are easy to incorporate in normal feed manufacturing process, and are easier to ship and store than liquid formulation.

The liquid formulation market is expected to grow at the highest rate of 8.80% CAGR, due to the increased preference of the producers for liquid formulation of eubiotics for the ease of dosage in liquid form, especially in case of poultry, which allows them to deliver eubiotics through the water line of the producer's facility.

Regional Analysis

Europe Eubiotics Market Insights

Europe holds the largest share of the global Eubiotics Market, at 37.0% of global revenue in 2025, anchored by among the strictest antibiotic regulations in the world under Regulation 2019/6 on veterinary medicinal products. That regulatory environment made eubiotic adoption close to mandatory rather than optional for European livestock producers well before most other regions followed suit, giving the region's manufacturers a meaningful head start in both expertise and brand credibility.

Germany leads the European market with a 28.40% share, supported by its large livestock industry and advanced feed additive manufacturing base, and is also the fastest-growing individual country market in the region as regulatory enforcement continues tightening. France and the Nordic countries follow, with demand across the region tied to comprehensive antibiotic-free farming mandates and strong animal welfare consumer expectations.

Get Customized Report as Per Your Business Requirement - Enquiry Now

North America Eubiotics Market Insights

North America's eubiotics market is mature and steady, anchored by comprehensive antibiotic growth promoter restrictions implemented under FDA Guidance for Industry #213 that pushed the region's poultry and swine producers toward eubiotic adoption years ago. Growth here now comes mostly from formulation upgrades and expanding aquaculture applications rather than first-time adoption, since the underlying regulatory shift away from antibiotics is largely complete across major livestock categories.

The United States accounts for approximately 84.60% of the North American market, reflecting its large livestock and poultry production base and well-established feed additive manufacturing infrastructure. Canada contributes a smaller but steady share, tied to its own livestock sector and comparable regulatory environment around antibiotic use.

Asia Pacific Eubiotics Market Insights

Eubiotics sales in Asia-Pacific are growing steadily as the region's huge livestock and aquaculture segments grow in size, but the region's market share lags that of Europe owing to variations in antibiotic regulations from country to country in the region. Huge livestock and growing aquaculture production in China, along with antibiotic-free livestock in Japan for premium meat exports, are key factors for the growth of this region.

China has almost 33.80% share in the regional market with its huge livestock and aquaculture production segments and feed additive production segments. Growth in Japan is steady at a faster rate than the global average on account of antibiotic-free livestock and meat exports, while India and Southeast Asian markets contribute through growing poultry, swine, and aquaculture productions.

Middle East & Africa and Latin America Eubiotics Market Insights

The Middle East & Africa region is growing faster than any other region in this market, as livestock production intensifies across the region and antibiotic-free farming practices gain traction alongside rising food safety expectations. Latin America's growth follows a similarly strong trajectory, driven by Brazil's massive livestock and poultry export industry and expanding aquaculture production across the region.

UAE holds the leading position in Middle East & Africa with a market share of 18.20% because of its status as a regional feed ingredient distribution center along with livestock import substitution activities. The share held by Brazil is 26.90% in the Latin American market due to the status of Brazil being one of the biggest exporters of livestock and poultry in the world.

Market Dynamics

Growth Drivers: Antibiotic Regulation and Livestock Production Growth Fueling Market Growth

Stringent regulation of antibiotics as growth promoters within a widening number of countries is the one clear factor that stands out as being responsible for the growing demand for eubiotics as farmers seek validated alternatives that can ensure productivity in their animals without using antibiotics for preventive purposes against diseases. The increase in global meat production to 374 million tonnes in 2024 and beyond represents a continuous growth in demand for meat and is an area where eubiotics companies will directly benefit.

Consumer demands for meat and dairy products free from antibiotics have been adding weight to the already existing regulatory pressures in favor of a product pull for eubiotics.

Restraints: Cost Premiums and Performance Variability Limiting Market Expansion

Feed additives for eubiosis tend to have a higher price tag than antibiotics, and this additional expense may be a real challenge for small producers who do not enjoy sufficient profit margins, especially those located in places that lack regulatory requirements for making this change. Performance outcomes of eubiotics may prove to be highly unpredictable compared to what producers expect them to be since these are living microbial products, and it is harder to predict their outcomes than those of chemicals.

Handling probiotic strains that require special care and control of temperatures is much more costly than working with chemical compound.

Opportunities: Aquaculture Expansion and Precision Formulation Creating New Growth Avenues

Aquaculture represents one of the clearest growth opportunities in this market, as fish and shrimp farming operations increasingly recognize eubiotics' specific value in water-quality-sensitive production environments where gut health directly affects both growth performance and disease resistance. Manufacturers who can develop species-specific formulations stand to capture premium positioning in this rapidly expanding application.

Precision formulation tailored to specific production stages, starter, grower, finisher diets, offers a second clear opportunity, particularly as producers increasingly recognize that a one-size-fits-all eubiotic approach leaves performance gains on the table compared to stage-specific formulations.

Recent Developments:

• February 2025: Novonesis A/S acquired dsm-firmenich's stake in the Feed Enzyme Alliance for EUR 1.5 billion, dissolving the joint venture and taking over its sales and distribution activities to strengthen its animal biosolutions portfolio.

• January 2025: Evonik Industries AG launched Ecobiol Soluble Plus, a water-soluble probiotic for poultry built around Bacillus amyloliquefaciens CECT 5940, at the Poultry India event in Hyderabad.

• December 2024: Novibio Inc. launched Poultrirom Plus, a new eubiotic product designed to enhance intestinal health in broilers and turkeys.

• 2025: DSM-Firmenich AG continued to expand its eubiotics portfolio, building on its earlier Biomin and Midori acquisitions, while transitioning its feed enzyme sales relationship to Novonesis under a long-term premix supply agreement.

Eubiotics Market key players are:

• Novonesis A/S

• DSM-Firmenich AG

• BASF SE

• Cargill, Incorporated

• Kemin Industries, Inc.

• Lallemand Inc.

• Novus International, Inc.

• BENEO GmbH

• Behn Meyer Group

• Alltech, Inc.

• Lesaffre Group

• AB Vista

• Calpis Co., Ltd.

• UAS Laboratories

• Yara International ASA

• Advanced BioNutrition Corp.

• Adisseo France SAS

• Evonik Industries AG

• Purina Animal Nutrition LLC

• Impextraco NV

Eubiotics Market Report Scope: